MeCure Industries reports it has secured approval from the National Agency for Food & Drug Administration and Control (NAFDAC) to launch production of the first locally manufactured alternative Amoxicillin- Clavulanic acid tablets, Amoxyclav 625mg.
This announcement comes at a crucial time following the departure of major manufacturers of similar variants, positioning MeCure Industries as a key player in meeting the nation’s healthcare needs.
MeCure Industries also stated it has successfully completed its Beta-lactam plant, focusing on the production of essential antibiotics such as Amoxyclav, its brand of Amoxicillin- Clavulanic acid tablets.
The company said production of Amoxyclav tablets commenced in the first quarter of 2024, with NAFDAC’s final approval obtained on April 30th, enabling the transition from import to locally produced status.
MeCure Industries has said it is fitting for its facilities to align with the standards set by the Beta-lactam plant. Additionally, the company has constructed a Corticosteroid manufacturing plant, nearing completion with a 90% rate achieved as of the first quarter of 2024.
Imported brands of the drugs range between N4000 and N8500 in some markets across the country.
MeCure Industries also reported it has embraced “innovative technolbytechnology” by launching a “state-of-the-art Track and Trace Solution,” becoming the first pharmaceutical manufacturing company in Nigeria to adopt this advanced system.
In the wake of the departure of major manufacturers of Amoxicillin-Clavulanic acid variants from the Nigerian market such as GlaxoSmithKline (GSK) and Sanofi, the healthcare landscape faced significant challenges.
Nairametrics has monitored the situation, reporting on the escalating prices and the impact on the Nigerian market.
As foreign-manufactured brands departed the market, there was a growing need for viable alternatives to ensure continued access to essential medications for the Nigerian populace.
With MeCure Industries planning to introduce locally manufactured Amoxicillin-Clavulanic acid tablets to the market, Nigerians will anticipate a more competitive pricng for the drug